The European Stroke Network

Size: px
Start display at page:

Download "The European Stroke Network"

Transcription

1 The European Stroke Network A Unique Alliance for Combating Stroke Prof. Dr. Stephen Meairs Department of Neurology University Medicine Mannheim University of Heidelberg, Germany

2 European Stroke Network 30 Partners from 14 countries

3 The European Stroke Network European Stroke Research Network (EUSTROKE) Coordinator: Prof. Stephen Meairs Affording Recovery in Stroke (ARISE) Coordinator: Prof. Ulrich Dirnagl

4 European Stroke Network Launch by European Commission in 2008

5

6

7

8 Primary Goals decrease the physical, social and economic consequences of stroke on the individual and on society achieve this objective by bringing together European researchers, government, industry, the non-profit sector and patient group associations

9 Research Themes of ESN Neurovascular Unit Regeneration Reperfusion Brain Immune Interaction / Inflammation Prevention / Neuroprotection

10 ESN Platforms Clinical Trial Platform (SITS) Stroke Models Imaging Training Patient group interaction (SAFE)

11 Challenges and opportunities of FP7 research Multidisciplinary Research

12 Multidisciplinary Research Complex problems demand multidisciplinary approach Utilize the opportunity to integrate researchers new to a particular clinical field Results can be very rewarding Challenge: Requires intensive dialogue and training

13 Challenges and opportunities of FP7 research Added Value

14 European Added Value A Tangible Advantage Going beyond research at a national level Cross fertilization of European research centers can lead to better results European cooperation is superior Fresh approaches to a problem provide higher impact Training opportunities, new research impulses Challenge: to stimulate added value in project

15 Neurovascular Unit

16 strategies that reduce vascular causes of injury to the brain tissue have been the most successful therapeutic approaches to limiting the extent of injury from ischemic stroke. the microvascular component of the neurovascular unit contributes to neuronal injury

17 The neurovascular unit circulating blood elements highly specialized endothelial cells pericytes embedded in the endothelial cell basement membrane perivascular antigen presenting cells astrocytic endfeet parenchymal basement membrane neurons

18 Research focus on NVU little understanding of molecular biology of the NVU interdisciplinary barriers - researchers in the different fields of vascular biology, neurobiology, physiology and cell biology neurons, glia and vascular cells are closely related developmentally, structurally and functionally neurovascular unit highlights the intimate functional relationships between these cells and their coordinated pattern of reaction to injury

19 New Models for Studying the NVU help identify the cellular and molecular mechanisms involved in NVU maintenance provide a basis for understanding how ischemia leads to breakdown of the NVU understand how the NVU contributes to reperfusion injury

20 Regeneration

21 Regeneration and Repair after stroke Molecular and cellular regulation of stroke-induced neurogenesis from endogenous neural stem/progenitor cells. Dynamics of structural recovery of surviving neurons and proliferation of glia cells in relation to axonal growth and expression of molecules involved in trafficking Effects of an antibody against Nogo-A on enhancing functional recovery.

22 Angiogenesis and vascular stabilization define factors able to induce mobilization from the bone marrow of endothelial and myeloid cell progenitors assess the potential of ex vivo administered vascular progenitor cells in reducing cerebral damage after acute cerebral vessel occlusion define the adhesion molecules and chemokines able to mediate the homing of these cells in the ischemic brain

23 Angiogenesis and vascular stabilization identify the growth factors which induce angiogenesis in the brain while retaining permeability properties and induce vessel maturation elucidate the optimal interaction of newly growing vessels with pericytes and neural cells identify the bi-directional signals between neural stem cells and brain endothelial cells

24 Targeted gene therapy and nanotechnology Targeted gene delivery of AAV vectors to the brain with microbubbles and ultrasound Encapsulated biodelivery of SDF1, meteorin, and BDNF for fostering stem cell migration and differentiation using MR-guided focused ultrasound

25 Transient opening of BBB with focused ultrasound 9,4 Tesla Bruker BioSpec 94/20 USR, rat brain MRI parameters: Insonation characteristics: T1 FLASH Frequency 1 MHz TR: 70 Burst length 10 ms TE: 2 Burst rate 1 Hz ST: MPa L: W: min insonation time Contrast agent: gadolinium (Gadovist )

26 Targeted delivery of AAV with focused ultrasound and lipoplex microbubbles Adeno-associated virus - Serotype raav2/1

27 Triggering regeneration in the brain Non-invasive targeted delivery of brain-derived neurotrophic factor to the brain with focused ultrasound and microbubbles Alexa488-BDNF 4h after ultrasound and microbubbles (BG6895) Rat brain cortex Vessel 80µm 20µm Left image: vessel (neg. for BDNF, left lower corner); multiple neurons staining strongly positive for BNDF (see arrows); punctuate staining possibly due to low uptake of BNDF in cells (not in control hemispheres!) Middle image: high magnification of neurons with very strong uptake of BNDF.

28 MR-guided Focused Ultrasound

29 Reperfusion

30 Neurotoxic effects of thrombolysis Identifying and testing nonneurotoxic thrombolytics Biomarkers to identify individual variability in response to thromboembolic arterial occlusion as well as risk of hemorrhage and neurotoxicity (microparticles)

31 Adjunct therapies for thrombolysis release tpa PAI-1 tpa activation pln a2-ap inhibition tpa plg pln inhibition Fibrin clot Breakdown FDPs Benchenane et al., Trends In Neurosciences, 2004

32

33

34

35 23Na concentration related intensity/ tissue vitality (T 2* -weighted 23Na MRI, Acquisition Time = 20min)

36 Immune Interaction / Inflammation

37 Inflammation in stroke Identify the efficacy of key anti-inflammatory strategies Determine the effect of systemic inflammation, investigate the mechanisms involved and explore new inflammatory biomarkers Test new inflammatory targets

38 Brain-immune interactions Explore the basic mechanisms of brain-immune interaction after stroke Establish predictive and sensitive clinical markers to describe the effect of stroke on the immune system

39 Prevention / Neuroprotection

40 Prevention of stroke via the NVU effects of functional foods and lipid-lowering drugs on NVU function and susceptibility to ischaemic stroke effects of physical exercise on the physiology of the neurovascular unit investigate whether physical activity and lipid-lowering influence endothelial progenitor cells, thus increasing susceptibility to stroke.

41 Endogenous neuroprotection Neuroprotective signaling Mechanisms of hypothermia induced neuroprotection Nasopharyngeal human brain cooling

42 Stroke model platform

43 Brain imaging platform

44 Training in stroke models and research

45 Close Cooperation between Experimental and Clinical Research

46 The ESN Trials Platform SITS Nils Wahlgren WSO Markku Kaste ESC Michael Hennerici ESO Werner Hacke TRANSLATION ESN Research Clinical Studies

47 Adapt the SITS network and database to support an ESN TRIALS PLATFORM (data entry and management, data sharing, etc) develop novel data entry procedures suitable for ambulatory use in prehospital settings and for acute phase intervention trials

48 Cooperation with Stroke Alliance for Europe

49 SAFE Activity in the ESN Engage in political efforts to foster government and EU funding of stroke research Assist in activities to raise private funds for support of future ESN research Support integration of national stroke research with the ESN to achieve high standards of European research

Sabrina Jedlicka 9/24/2012. NEUROENGINEERING: Interactions of Neurons and Materials

Sabrina Jedlicka 9/24/2012. NEUROENGINEERING: Interactions of Neurons and Materials Sabrina Jedlicka 9/24/2012 NEUROENGINEERING: Interactions of Neurons and Materials What is neuroengineering? Neuroengineering combines engineering and computational approaches to problems in basic and

More information

Hypoxic Preconditioning Strategy for Stem Cell Transplantation Therapy after Ischemic Stroke

Hypoxic Preconditioning Strategy for Stem Cell Transplantation Therapy after Ischemic Stroke The 13 th International Conference on Dose-Response Preconditioning: Adaptive Responses in Biology and Medicine; UMass Amherst Hypoxic Preconditioning Strategy for Stem Cell Transplantation Therapy after

More information

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 Developing Targeted Stem Cell Therapeutics for Cancer Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 The Challenge of Drug Delivery for Brain Cancer Stem Cells

More information

Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders

Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders ProFiDIΛ Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders THROMBOLYSIS WITH IMPROVED SAFETY A valorisation project of Unmet Medical Need = Safe Thrombolysis

More information

Concept of Integrated Research Platforms

Concept of Integrated Research Platforms Concept of Integrated Research Platforms Michal Vlasin UVPS Brno, Czech Republic Lumir Krejci October 21, 2010 INTEGRATED RESEARCH PLATFORMS AC: Animal Center CBCE: Center of Biomolecular and Cellular

More information

leading the way in research & development

leading the way in research & development leading the way in research & development people. passion. possibilities. ABBVIE 2 immunology AbbVie Immunology has a demonstrated record of success in identifying and developing both small molecule and

More information

for SCI: Challenges for Entry and Execution of Phase 1 Clinical Trials Challenges and Opportunities of Cellular Therapeutic Development

for SCI: Challenges for Entry and Execution of Phase 1 Clinical Trials Challenges and Opportunities of Cellular Therapeutic Development Case Study: Human Embryonic Stem Cell Based Therapy for SCI: Challenges for Entry and Execution of Phase 1 Clinical Trials Jane S Lebkowski Ph.D NHLBI-PACT Workshop Sept 15, 2011 Challenges and Opportunities

More information

Handy Gelbard, Director Professor of Neurology, Pediatrics, Microbiology & Immunology and Neuroscience

Handy Gelbard, Director Professor of Neurology, Pediatrics, Microbiology & Immunology and Neuroscience The Center for Neural Development and Disease (will be The Center for NeuroTherapeutics Discovery) Handy Gelbard, Director Professor of Neurology, Pediatrics, Microbiology & Immunology and Neuroscience

More information

Myelin Repair Foundation Research Progress Report June 2006-July 2007

Myelin Repair Foundation Research Progress Report June 2006-July 2007 Myelin Repair Foundation Research Progress Report June 2006-July 2007 In July 2004, the Myelin Repair Foundation initiated a five-year research plan with the mission of discovering and validating new therapeutic

More information

Cell-penetrating peptides: news for dated cellular Trojan horses

Cell-penetrating peptides: news for dated cellular Trojan horses Technical Journal Club Cell-penetrating peptides: news for dated cellular Trojan horses Assunta Senatore August 5 th 2014 Overview Cell-penetrating peptides: classes and mechanisms of cell entry Overview

More information

Growth factor delivery

Growth factor delivery Growth factor delivery S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative of IITs

More information

UNCLASSIFIED R-1 ITEM NOMENCLATURE

UNCLASSIFIED R-1 ITEM NOMENCLATURE COST ($ in Millions) All Prior FY 2014 Years FY 2012 FY 2013 # Base FY 2014 FY 2014 OCO ## Total FY 2015 FY 2016 FY 2017 FY 2018 Cost To Complete Total Program Element - 44.445 39.676 49.500-49.500 51.500

More information

SmartPReP 2: The Gold Standard

SmartPReP 2: The Gold Standard The Optimal Platelet Rich Plasma Composition SmartPReP 2: The Gold Standard Harvest Technologies is the leader in developing point-of-care cellular platforms to isolate and concentrate autologous growth

More information

Project Final Report

Project Final Report Project Final Report Grant Agreement number: 201024 Project acronym: ARISE Project title: Affording recovery in stroke Funding Scheme: Collaborative project Date of latest version of Annex I against which

More information

Preclinical development for SSc indications NO COPY. a preclinical portfolio in a perfect world. Jörg Distler

Preclinical development for SSc indications NO COPY. a preclinical portfolio in a perfect world. Jörg Distler Preclinical development for SSc indications a preclinical portfolio in a perfect world Jörg Distler Department of Internal Medicine 3 and Institute for Clinical Immunology University of Erlangen-Nuremberg

More information

OMM Research From Bedside to Bench and Back Again. Dr. Rzigalinski - DrZ

OMM Research From Bedside to Bench and Back Again. Dr. Rzigalinski - DrZ OMM Research From Bedside to Bench and Back Again Dr. Rzigalinski - DrZ brzigali@vcom.vt.edu 231-1744 We Know It Works, But We Need Evidence- Based Studies Basic Biomedical Animal Studies Clinical Studies

More information

At the conclusion of this lesson you should be able to:

At the conclusion of this lesson you should be able to: Learning Objectives At the conclusion of this lesson you should be able to: Understand the key terms and definitions regarding stem cells Differentiate between the adult and embryonic stem cells Differentiate

More information

Marie Skłodowska-Curie European Fellowship

Marie Skłodowska-Curie European Fellowship Marie Skłodowska-Curie European Fellowship Expression of Interest Application Form 2017 This form must be completed for Expressions of Interest (EoIs) to the Marie Skłodowska-Curie European Fellowship

More information

THE SCIENCE OF PLATELET RICH PLASMA

THE SCIENCE OF PLATELET RICH PLASMA THE SCIENCE OF PLATELET RICH PLASMA Cheri A. Ong, MD FACS ONG INSTITUTE FOR PLASTIC SURGERY & HEALTH WHAT IS PRP BLOOD PLASMA 55% of the body s today body volume 45% blood cells:- Red blood cells, White

More information

Article: "Noninvasive and Targeted Gene Delivery into the Brain Using Microbubble-Facilit 1 / 16. Ultrasound" Malova Anna

Article: Noninvasive and Targeted Gene Delivery into the Brain Using Microbubble-Facilit 1 / 16. Ultrasound Malova Anna Article: "Noninvasive and Targeted Gene Delivery into the Brain Using Microbubble-Facilitated Focused Ultrasound" 06.04.2013 Article: "Noninvasive and Targeted Gene Delivery into the Brain Using 06.04.2013

More information

J ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION

J ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION J ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION J ove VIDEO JOURNAL The first scientific video journal dedicated to advancing science by increasing reproducibility and efficient

More information

The Cell and Gene Therapy Catapult UK clinical trials database

The Cell and Gene Therapy Catapult UK clinical trials database The Cell and Gene Therapy Catapult UK clinical trials database The UK clinical trials database covers cell and gene therapy clinical trial activities that the Cell and Gene Therapy Catapult (CGT Catapult)

More information

Tissue Engineering and the Brain. Susan Perry Bioengineering Program Lehigh University

Tissue Engineering and the Brain. Susan Perry Bioengineering Program Lehigh University Tissue Engineering and the Brain Susan Perry Bioengineering Program Lehigh University ...all the most acute, most powerful, and most deadly diseases, and those which are most difficult to be understood

More information

Structure of IgG and IgM

Structure of IgG and IgM Structure of IgG and IgM Fig. 5-1 A,B Crystal Structure of Secreted IgG Fig. 5-1 C Structure of an Ig Domain Fig. 5-2 Proteolytic Fragments of IgG (1) Fig. 5-3A Proteolytic Fragments of IgG (2) Fig. 5-3B

More information

FOR 2325 Interactions at the Neurovascular Interface. International Symposium. Cellular and Molecular Processes at the Neurovascular Interface

FOR 2325 Interactions at the Neurovascular Interface. International Symposium. Cellular and Molecular Processes at the Neurovascular Interface FOR 2325 Interactions at the Neurovascular Interface International Symposium Cellular and Molecular Processes at the Neurovascular Interface April 24 25, 2018 Campus Westend Casinogebäude, Conference room

More information

STEM CELLS IN NEUROLOGY ISABELLE COCHRANE MERIT

STEM CELLS IN NEUROLOGY ISABELLE COCHRANE MERIT STEM CELLS IN NEUROLOGY BY ISABELLE COCHRANE MERIT RESEARCH PAPER BASED ON PATHOLOGY LECTURES AT MEDLINK 2011 1 Abstract Ever since their discovery, stem cells have been heralded as the ultimate cure to

More information

KRISANI BIO SCIENCES PVT. LTD.

KRISANI BIO SCIENCES PVT. LTD. KRISANI BIO SCIENCES PVT. LTD. Flat B2, 2 nd Floor, Suryateja Apartments, Hindi Nagar, Punjagutta, Hyderabad, Telangana 500078. Email: kkr@krisanibio.com. URL: www.krisanibio.com Contact Number: +91 98494

More information

The Cell and Gene Therapy Catapult UK clinical trials database

The Cell and Gene Therapy Catapult UK clinical trials database The Cell and Gene Therapy Catapult UK clinical trials database The UK clinical trials database covers cell and gene therapy clinical trial activities that the Cell and Gene Therapy Catapult (CGT Catapult)

More information

Office of Patents and Licensing STEM CELLS & TISSUE ENGINEERING

Office of Patents and Licensing STEM CELLS & TISSUE ENGINEERING 1 STEM CELLS & TISSUE ENGINEERING Technology : University of Medicine and Dentistry of New Jersey 335 George Street, New Brunswick, NJ 08901 Direct Phone: (732)-235-9355 Office Phone: (732)-235-9350 Fax:

More information

UNCLASSIFIED UNCLASSIFIED

UNCLASSIFIED UNCLASSIFIED COST(In Millions) FY 1998 FY 1999 FY 2000 FY 2001 FY 2002 FY 2003 FY 2004 FY 2005 Cost to Complete Total Cost Total Program Element (PE) 1.495 2.167 2.033 2.021 2.102 2.099 2.143 2.188 Continuing Continuing

More information

Insight Through In Vivo Imaging

Insight Through In Vivo Imaging Insight Through In Vivo Imaging Resolution Revolution in Realtime The Vevo 770 provides anatomical, functional and molecular data in realtime, on an affordable, easy to use and translational platform.

More information

Stem Cel s Key Words:

Stem Cel s Key Words: Stem Cells Key Words: Embryonic stem cells, Adult stem cells, ips cells, self-renewal, differentiation, pluripotent, multipotent, Inner cell mass, Nuclear transfer (Therapeutic cloning), Feeder cells,

More information

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York European Regenerative Medicine Firms & Their Strategic Approaches Michael Morrison University of York OVERVIEW Creating the European RM Universe of firms Characterizing the European RM Universe Strategic

More information

Tadanori Ogata 1, Hideki Horiuchi 1, Tadao Morino 1, Sintaro Yamaoka 1, Hiromasa Miura 2.

Tadanori Ogata 1, Hideki Horiuchi 1, Tadao Morino 1, Sintaro Yamaoka 1, Hiromasa Miura 2. Intrathecal injection of autologous macrophages genetically modified to secrete BDNF by ex vivo electroporation improves hind limb motor function after thoracic spinal cord injury in rats. Tadanori Ogata

More information

The Leader in AAV Gene Therapy. A Guide to AAV Gene Therapy for MPS I and II

The Leader in AAV Gene Therapy. A Guide to AAV Gene Therapy for MPS I and II The Leader in AAV Gene Therapy A Guide to AAV Gene Therapy for MPS I and II REGENXBIO seeks to understand the diverse perspectives of patients, caregivers and families, and to learn from their experiences

More information

A/Prof Bronwen Connor Neural Repair and Neurogenesis Lab Dept of Pharmacology & Clinical Pharmacology Centre for Brain Research University of

A/Prof Bronwen Connor Neural Repair and Neurogenesis Lab Dept of Pharmacology & Clinical Pharmacology Centre for Brain Research University of A/Prof Bronwen Connor Neural Repair and Neurogenesis Lab Dept of Pharmacology & Clinical Pharmacology Centre for Brain Research University of Auckland Overview What is a stem cell? Discovery - our research

More information

Cell membrane repair in acute lung injury: from bench to bedside. Disclosure. Cell membrane repair is an elemental physiological process

Cell membrane repair in acute lung injury: from bench to bedside. Disclosure. Cell membrane repair is an elemental physiological process Cell membrane repair in acute lung injury: from bench to bedside Disclosure Jianjie Ma, Ph.D. Karl P. Klassen Chair of Thoracic Surgery Department of Surgery Davis Heart and Lung Research Institute The

More information

Translation of Biomaterial-based Therapies for the Treatment of Spinal Cord Injury: The Neuro-Spinal Scaffold and Bioengineered Neural Trails

Translation of Biomaterial-based Therapies for the Treatment of Spinal Cord Injury: The Neuro-Spinal Scaffold and Bioengineered Neural Trails Translation of Biomaterial-based Therapies for the Treatment of Spinal Cord Injury: The Neuro-Spinal Scaffold and Bioengineered Neural Trails Alex A. Aimetti, PhD Sr. Director, Medical Education October

More information

QPS Neuropharmacology Overview

QPS Neuropharmacology Overview HISTOCHEMISTRY HISTOLOGY KO MODELS IN VIVO MODELS BLOOD BRAIN BARRIER IN VITRO MODELS NEUROPHARMACOLOGY OVERVIEW NEUROSCIENCES QPS Neuropharmacology Overview QPS is recognized all over the world as a leading

More information

Gene therapy. Findings by Alert

Gene therapy. Findings by Alert Gene therapy Published Mar 21, 2000 Version 1 Findings by Alert Research in gene therapy has increased dramatically during the past 15 years, particularly in the United States. The research has encompassed

More information

Chapter 8 Healthcare Biotechnology

Chapter 8 Healthcare Biotechnology Chapter 8 Healthcare Biotechnology Outline: 8.1 Introduction 8.2 Biopharming 8.3 Models of Human Disease 8.4 Detecting and Diagnosing Human Disease 8.5 Monoclonal Antibodies 8.6 Gene Therapy 8.7 Tissue

More information

Biomedical Sciences (Medical) (BMSC)

Biomedical Sciences (Medical) (BMSC) Biomedical Sciences (Medical) (BMSC) 1 Biomedical Sciences (Medical) (BMSC) Courses BMSC 8001. Introduction to Biochemistry and Molecular Biology. 3 Credit Hours. Graduate level course that describes fundamentals

More information

Opportunities for industry/smes in EU-funded health research

Opportunities for industry/smes in EU-funded health research Opportunities for industry/smes in EU-funded health research Stéphane Hogan, M.Sc, MBA Head of Unit Applied Genomics and Biotechnology for Health DG Research - European Commission 1 Paris, 31 May 2005

More information

EU support for Health Research from FP6 to FP7

EU support for Health Research from FP6 to FP7 EU support for Health Research from FP6 to FP7 Stéphane Hogan Head of Biotechnology Unit Directorate for Health Research DG Research - European Commission Valencia - 15 September 2006 EU research programmes

More information

FDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps

FDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps FDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps September 27, 2018 Presentation by: Elaine H. Tseng Partner FDA and Life Sciences Group King & Spalding Discussion with: Thomas Poché Vice

More information

Axol Bioscience SNAPSHOT PRESENTATION ELRIG ADVANCES IN CELL BASED SCREENING Zoe Allen, PhD Product Specialist

Axol Bioscience SNAPSHOT PRESENTATION ELRIG ADVANCES IN CELL BASED SCREENING Zoe Allen, PhD Product Specialist Axol Bioscience SNAPSHOT PRESENTATION ELRIG ADVANCES IN CELL BASED SCREENING 2017 Zoe Allen, PhD Product Specialist z.allen@axolbio.com Overview human cell culture systems induced pluripotent stem cells

More information

IV tpa: 1996 to Present

IV tpa: 1996 to Present IV tpa: 1996 to Present Where We ve Come From & What We ve Learned 1 Many of the things that seem impossible now will become realities of tomorrow. 2 Streptococcus Discovered back in the 1930s Activates

More information

Cell and Gene Therapy Catapult clinical trials database

Cell and Gene Therapy Catapult clinical trials database Cell and Gene Therapy Catapult clinical trials database Executive summary The number of cell and gene therapy clinical trials in the UK continues to increase with 85 ongoing trials at present, representing

More information

Preclinical MRI. Solutions for Small Animal Imaging. Molecular Imaging

Preclinical MRI. Solutions for Small Animal Imaging. Molecular Imaging Preclinical MRI Solutions for Small Animal Imaging Molecular Imaging The Power of Imaging Applications Resolution Typical resolution in MRI is less than 200μm, to more than 20μm with 2D slices or full

More information

Nanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management

Nanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management Nanotechnology: A Brief History and Its Convergence with Medicine Weston Daniel, PhD Director of Program Management Outline Introduction The Nanoscale Applications Realization of a Vision There s Plenty

More information

Research Strategy Delivering internationally excellent research for a healthy, safe and sustainable society

Research Strategy Delivering internationally excellent research for a healthy, safe and sustainable society Research Strategy 2016-2018 Delivering internationally excellent research for a healthy, safe and sustainable society Mission The College of Biomedical and Life Sciences aims to deliver internationally

More information

Stem Cells: Introduction and Prospects in Regenerative Medicine.

Stem Cells: Introduction and Prospects in Regenerative Medicine. Stem Cells: Introduction and Prospects in Regenerative Medicine www.gothamgazette.com/.../stemcell/stem_cell.jpg Ode to a Stem Cell, Part II by VCW There once was stem cell stuck in the hood Dividing endlessly,

More information

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development University of Wisconsin-Madison, Production Assistance for Cellular Therapies (PACT) Over the

More information

Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL

Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL Outcomes in Mesenchymal Stem Cell Manufacturing Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL Background HCTL established in 1992 to support BMT programs of Mayo

More information

Regulatory Challenges for the Development of Allogeneic Mesenchymal Stem Cell Products. Rod Monroy, Ph.D. Director, Prochymal

Regulatory Challenges for the Development of Allogeneic Mesenchymal Stem Cell Products. Rod Monroy, Ph.D. Director, Prochymal Regulatory Challenges for the Development of Allogeneic Mesenchymal Stem Cell Products Rod Monroy, Ph.D. Director, Prochymal Safe harbor This presentation contains, and answers given to questions that

More information

Barbara Alving, MD Director, National Center for Research Resources 6701 Democracy Boulevard MSC 4874 Bethesda, MD

Barbara Alving, MD Director, National Center for Research Resources 6701 Democracy Boulevard MSC 4874 Bethesda, MD Barbara Alving, MD Director, National Center for Research Resources 6701 Democracy Boulevard MSC 4874 Bethesda, MD 20892-4874 Via e-mail: PLANEVAL@mail.nih.gov Dear Dr. Alving: The American Society of

More information

OUR WISH LIST RESEARCH EQUIPMENT

OUR WISH LIST RESEARCH EQUIPMENT OUR WISH LIST RESEARCH EQUIPMENT YOU CAN MAKE A TANGIBLE DIFFERENCE! The South Australian Health and Medical Research Institute (SAHMRI) is one of the most exciting developments in the field of health

More information

OUR WISH LIST RESEARCH EQUIPMENT

OUR WISH LIST RESEARCH EQUIPMENT OUR WISH LIST RESEARCH EQUIPMENT WITH YOUR PHILANTHROPIC SUPPORT, WE CAN WORK TOGETHER TO COMPLETE OUR FULLY-FUNCTIONAL FACILITY BY PURCHASING THE CUTTING-EDGE EQUIPMENT AND RESOURCES TO SUPPORT SAHMRI

More information

NEURONAL CELL CULTURE MATRIX FOR BETTER MAINTENANCE AND SURVIVAL OF NEURONAL CELL CULTURES IN TISSUE CULTURE.

NEURONAL CELL CULTURE MATRIX FOR BETTER MAINTENANCE AND SURVIVAL OF NEURONAL CELL CULTURES IN TISSUE CULTURE. NEURONAL CELL CULTURE MATRIX FOR BETTER MAINTENANCE AND SURVIVAL OF NEURONAL CELL CULTURES IN TISSUE CULTURE. D. R. Aguirre, N. DiMassa, Chrystal Johnson, H. Eran, R. Perez, C.V.R. Sharma, M.V.R. Sharma,

More information

REIMAGINING DRUG DEVELOPMENT:

REIMAGINING DRUG DEVELOPMENT: Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY

More information

Stem Cells Canadian Perspective

Stem Cells Canadian Perspective Stem Cells Canadian Perspective John Laffey Critical Illness and Injury Research Centre, Keenan Research Centre, St Michael s Hospital. Departments of Anesthesia, Physiology and Interdepartmental Division

More information

Linker p. 177 Helper Lipid p. 178 Delivery to Target Cells p. 180 Cell Entry p. 182 Receptor-Mediated Uptake p. 182 Endosomai Release p.

Linker p. 177 Helper Lipid p. 178 Delivery to Target Cells p. 180 Cell Entry p. 182 Receptor-Mediated Uptake p. 182 Endosomai Release p. Overview of Regulatory Expectations for Introducing Novel Therapies into Clinical Trials Introduction p. 1 Roles of Regulatory Scientists p. 2 Product Development and Availability p. 2 Data Requirements

More information

Development of new polymeric biomaterials for in vitro and in vivo liver reconstruction

Development of new polymeric biomaterials for in vitro and in vivo liver reconstruction SIXTH FRAMEWORK PROGRAMME PRIORITY 3 NMP- Nanotechnology and nano sciences, knowledge-based multifunctional materials and new production processes and devices Development of new polymeric biomaterials

More information

The Swedish Foundation for Strategic Research (SSF) announces a. call for proposals in the areas of

The Swedish Foundation for Strategic Research (SSF) announces a. call for proposals in the areas of 1(8) 2008-09-16 Announcement The Swedish Foundation for Strategic Research (SSF) announces a call for proposals in the areas of Design, development and validation of new predictive models and new biomarkers

More information

Stem cells and motor neurone disease

Stem cells and motor neurone disease Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and includes details of the current

More information

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics Molecular Medicine Molecular Medicine Stem cell therapy Gene therapy Tumor therapy Immunotherapy Other therapies Vaccines Genetic diagnostics Medical genomics Medication Diagnostics medicine: old desire

More information

Anika Therapeutics, Inc.

Anika Therapeutics, Inc. Anika Therapeutics, Inc. Jefferies Global Healthcare Conference June 4, 2015 Safe Harbor Statement The statements made in this presentation that are not statements of historical fact are forward looking

More information

2015 State of the Science in Transfusion Medicine Overarching themes and specific questions for RBCs What s in the [RBC] bag? Identify and quantify the components of RBC products to improve the quality,

More information

BUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care.

BUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care. BUILT TO CONCENTRATE Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care. DELIVER PERSONALIZED MEDICINE Every patient has a unique biology

More information

List of E-journals Subscribed for the year 2016 (January to December) Pharmacy Faculty Sl. No.

List of E-journals Subscribed for the year 2016 (January to December) Pharmacy Faculty Sl. No. Faculty 1 Adolescent Psychiatry Psychiatry 2 Anti Cancer Agents in Medicinal / Pharma & Quality 3 Anti-Infective Agents Pharmaceutical Microbiology 4 Anti-Inflammatory & Anti- Allergy Agents in Medicinal

More information

Caplacizumab. Wholly-owned anti-vwf Nanobody

Caplacizumab. Wholly-owned anti-vwf Nanobody 1 Caplacizumab Wholly-owned anti-vwf Nanobody First-in-class bivalent Nanobody with Orphan Drug Status and patent protection up to 2035 Developed for the treatment of acquired thrombotic thrombocytopenic

More information

ALL THE ESSENTIALS OF HEALING, NATURALLY

ALL THE ESSENTIALS OF HEALING, NATURALLY ALL THE ESSENTIALS OF HEALING, NATURALLY Harvest Technologies Developing Cellular platforms that may help optimize conditions for healing orthopedic sites Unlocking the Biologic Potential What is the Optimal

More information

Alex A. Aimetti, PhD Sr. Director, Medical Education October 29, InVivo Therapeutics

Alex A. Aimetti, PhD Sr. Director, Medical Education October 29, InVivo Therapeutics Translation of Biomaterial-based Therapies for the Treatment of Acute and Chronic Spinal Cord Injury: The Neuro-Spinal Scaffold and Bioengineered Neural Trails Alex A. Aimetti, PhD Sr. Director, Medical

More information

Research area in the Strategic Objective Development of optical control technologies and elucidation of biological mechanisms

Research area in the Strategic Objective Development of optical control technologies and elucidation of biological mechanisms Research area in the Strategic Objective Development of optical control technologies and elucidation of biological mechanisms 6.1.5 Development and application of optical technology for spatiotemporal

More information

All THE E SSEn TIAl S OF H EAl I ng, natu RAlly. P RIvATE PRACTICE

All THE E SSEn TIAl S OF H EAl I ng, natu RAlly. P RIvATE PRACTICE All THE E SSEn TIAl S OF H EAl I ng, natu RAlly P RIvATE PRACTICE Harvest Technologies Developing Cellular platforms that may help optimize conditions for healing orthopedic sites Unlocking the Biologic

More information

SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website]

SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website] SCM Lifescience [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea 22332 [Website] http://www.scmlifescience.com COMPANY PROFILE [Industry] SCM Lifescience is a research-based biopharmaceutical company

More information

Translational Research

Translational Research Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic

More information

Page 1 of 5 Message from the Director: As the summer kicks off, many of us will renew our focus on research and scholarship. Towards this goal, we draw your attention to a several upcoming events and opportunities

More information

The Cardiovascular System: Blood

The Cardiovascular System: Blood The Cardiovascular System: Blood The Functions of Blood General Overview Provides a system for rapid transport within the body Nutrients Hormones Waste products Respiratory gases Cells & Blood Components

More information

A Physiological Cell based Microchip Platform. 1

A Physiological Cell based Microchip Platform.   1 A Physiological Cell based Microchip Platform www.synvivobio.com 1 Drug Development Problem What passes here often fails here Discovery Pre clinical Clinical Trials in vitro in vivo Static Well plate Platforms

More information

UvA-DARE (Digital Academic Repository) Factor XI as target for antithrombotic therapy van Montfoort, M.L. Link to publication

UvA-DARE (Digital Academic Repository) Factor XI as target for antithrombotic therapy van Montfoort, M.L. Link to publication UvA-DARE (Digital Academic Repository) Factor XI as target for antithrombotic therapy van Montfoort, M.L. Link to publication Citation for published version (APA): van Montfoort, M. L. (2014). Factor XI

More information

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003 Lecture 17: Drug targeting Last time: Today: Intracellular drug delivery Drug targeting Reading: T.J. Wickham, Ligand-directed targeting of genes to the site of disease, Nat. Med. 9(1) 135-139 (2003) Drug

More information

Production and commercialisation of vascularized and customized bone Clinical trials, market authorisation Pre-clinical trials

Production and commercialisation of vascularized and customized bone Clinical trials, market authorisation Pre-clinical trials Production and commercialisation of vascularized and customized bone Clinical trials, market authorisation Pre-clinical trials Basic Research: scaffolds, cells/ media, in vivo imaging, modelling www.vascubone.eu

More information

TOP ST. search articles. ' s. . Discovery brings with it possible implications for brain regeneration -

TOP ST. search articles. ' s.  . Discovery brings with it possible implications for brain regeneration - Like 1.1M Follow 0 Research News Clinical Updates Publications NeuroInsights Product News search articles Scientists discover neuron-producing stem cells in the membranes covering the brain November 23,

More information

When should non human primates be used as animal models?

When should non human primates be used as animal models? When should non human primates be used as animal models? Roger Lemon Sobell Department of Motor Neuroscience and Movement Disorders UCL Institute of Neurology Queen Square Animal Research Regulation Meeting

More information

CRITERIA FOR PROJECT SELECTION

CRITERIA FOR PROJECT SELECTION CRITERIA FOR PROJECT SELECTION The CITN is a network of eperienced immunotherapy investigators with inherently diverse research interests. Thus, we have established guidelines to epedite project selection

More information

PRE-HOSPITAL AND PERIPROCEDURE NEUROPROTECTION: THE FAST AND THE FURIOUS. William J. Mack, MD, MS, FAANS, FAHA

PRE-HOSPITAL AND PERIPROCEDURE NEUROPROTECTION: THE FAST AND THE FURIOUS. William J. Mack, MD, MS, FAANS, FAHA PRE-HOSPITAL AND PERIPROCEDURE NEUROPROTECTION: THE FAST AND THE FURIOUS William J. Mack, MD, MS, FAANS, FAHA Associate Professor of Neurosurgery Neuroscience Graduate Program Zilkha Neurogenetic Institute

More information

1 Ultrasound targeting

1 Ultrasound targeting This lecture deals with the concepts involved in ultrasound targeting and the challenges involved therein. A snapshot of the challenges involved in targeting the brain acrosss the blood-brain barrier (BBB)

More information

Molecular Imaging. by Magnetic Resonance. Silvio Aime. University of Torino (Italy) Department of Chemistry IFM & Molecular Imaging Center

Molecular Imaging. by Magnetic Resonance. Silvio Aime. University of Torino (Italy) Department of Chemistry IFM & Molecular Imaging Center Molecular Imaging by Magnetic Resonance Silvio Aime University of Torino (Italy) Department of Chemistry IFM & Molecular Imaging Center Molecular Imaging In vivo characterization and quantitative measurement

More information

Jefferies Healthcare Conference 2016

Jefferies Healthcare Conference 2016 Jefferies Healthcare Conference 2016 Forward looking Statement This presentation concerning Pluristem Therapeutics may include forward-looking statements which represent Pluristem Therapeutics' expectations

More information

Instructor: Laboratory Location: Contact Information: Website: Course Information: Research Interests: Instructor: Laboratory Location:

Instructor: Laboratory Location: Contact Information: Website: Course Information: Research Interests: Instructor: Laboratory Location: Exciting Research Opportunities For Undergraduate Honors Students At The University of Toledo College of Medicine and Life Sciences!!! Please see the list of faculty and research interests below for exciting

More information

Characterization and Functional Analysis of a Newly Identified Human MT5-MMP Transcript Variant Isolated from Multipotent NT2 Cells

Characterization and Functional Analysis of a Newly Identified Human MT5-MMP Transcript Variant Isolated from Multipotent NT2 Cells Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2006 Characterization and Functional Analysis of a Newly Identified Human MT5-MMP Transcript Variant Isolated

More information

Promises and Challenges

Promises and Challenges Vladimir Mironov & Richard Visconti Regenerative Medicine: Promises and Challenges What is Regenerative Medicine? Regeneration is a well known biological term and phenomenon. According to the popular Webster

More information

Des cellules-souches dans le poumon : pourquoi faire?

Des cellules-souches dans le poumon : pourquoi faire? Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland

More information

Therapeutic Cell Replacement. Steven McLoon Department of Neuroscience University of Minnesota

Therapeutic Cell Replacement. Steven McLoon Department of Neuroscience University of Minnesota Therapeutic Cell Replacement Steven McLoon Department of Neuroscience University of Minnesota 1 Neuronal Death Neurons are lost due to four main causes: Trauma Toxin Hypoxia (typically loss of air or blood

More information

Erectile and voiding dysfunction: will stem cells solve it all?

Erectile and voiding dysfunction: will stem cells solve it all? Erectile and voiding dysfunction: will stem cells solve it all? Maarten Albersen MD PhD Dept. of Development and Regeneration Leuven University, Belgium Disclosures No conflicts of interest. ED stem cell

More information

Therapeutic Cell Replacement. Steven McLoon Department of Neuroscience University of Minnesota

Therapeutic Cell Replacement. Steven McLoon Department of Neuroscience University of Minnesota Therapeutic Cell Replacement Steven McLoon Department of Neuroscience University of Minnesota 1 Course News Coffee Hour Wednesday (Dec 13) Thursday (Dec 14) Friday (Dec 15) 9:00-10:00am Surdyk s Café in

More information

Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018

Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018 Adult Stem Cells for Chronic Pain Dr. John Hughes, DO January 24 th, 2018 Dr. John Hughes, DO Doctor of Osteopathy From Georgia Arizona College of Osteopathic Medicine - 2007 Aspen Integrative Medicine

More information

Stem Cell Services. Driving Innovation for Stem Cell Researchers

Stem Cell Services. Driving Innovation for Stem Cell Researchers Driving Innovation for Stem Cell Researchers Stem Cell Services Partner with us and have access to the most advanced and comprehensive stem cell services available today. 675 W. Kendall St. Cambridge,

More information